Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052
Amy Greer, Alexandra Valsamakis, Cholticha Ruangyuttikarn(Chiang Mai University), Myron S. Cohen(University of North Carolina at Chapel Hill), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Estelle Piwowar‐Manning(Johns Hopkins University), Sharlaa Badal‐Faesen(University of the Witwatersrand), Victor Akelo(Centers for Disease Control and Prevention), Michael Forman(Johns Hopkins Hospital), Marybeth McCauley(Family Health International 360), Chloe L. Thio(Johns Hopkins University), Ravindre Panchia(Chris Hani Baragwanath Hospital), Ethan Wilson(Fred Hutch Cancer Center), Theresa Gamble(University of Utah), José Henrique Pilotto(Universidade Iguaçu), Susan H. Eshleman(Johns Hopkins University), Ying Qing Chen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Mulinda Nyirenda(University of Malawi), Nagalingeswaran Kumarasamy, Joseph Makhema(University of Namur), San-San Ou(Fred Hutch Cancer Center), Marineide Gonçalves de Melo(Hospital Nossa Senhora da Conceição), Natthapol Kosashunhanan(Chiang Mai University), Mina C. Hosseinipour
Cited by 17
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k